Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIG Regulatory News (SHI)

Share Price Information for SIG (SHI)

Share Price is delayed by 15 minutes
Get Live Data
8.01    -0.14 (-1.72%)
Bid:
7.92
Ask:
8.10
Spread: 0.18 (2.273%)
Market Cap: £92.58m
SHI Live PriceLast checked at - London Stock Exchange

Intraday SIG Share Chart

Director/PDMR Shareholding

18 Sep 2015 09:44

RNS Number : 4973Z
SIG PLC
18 September 2015
 



SIG plc

18 September 2015

Ordinary Shares of 10p each

 

SIG plc (the "Company") announces that on 17 September 2015 it granted awards in the UK over ordinary shares in the Company in connection with the SIG plc 2014 Long Term Incentive Plan ("LTIP").

 

Pursuant to DTR 3.1.4 and following notifications received on 17 September 2015 in fulfilment of the obligations imposed by DTR 3.1.2 we hereby announce that the following awards have been granted to PDMRs.

 

Director/PDMR

Position

2015 LTIP

Award

Exercise Price (pence)

Total number of shares over which awards now held

Mr S R Mitchell

 

Group Chief Executive

455,838

NIL

1,392,440

Mr D G Robertson

Group Finance Director

274,323

NIL

908,982

Mrs L H Kennedy-McCarthy

Group HR Director

142,977

NIL

287,207

Mr R T Barclay

 

Managing Director -

UK & Ireland

169,074

NIL

511,230

Mr M Pearson

 

Group Chief Information Officer

95,264

NIL

146,932

Mr L Lvovich

Corporate Development Director

103,429

NIL

103,429

 

The awards take the form of nil cost options, being an option under the LTIP, with a nil exercise price.

 

Subject to the rules of the LTIP and the satisfaction of the performance conditions detailed below, the earliest vesting date of the award is normally 16 September 2018.

 

 

The performance conditions subject to which the options have been granted are as follows:

 

1. Two thirds of the award is subject to a condition as to the average return on capital employed (ROCE) over the Performance Period (the "ROCE Tranche"). The period over which the ROCE performance condition will be measured will be the period of three financial years 31 December 2015, 2016 and 2017.

Average Return on Capital Employed (ROCE) for FY2015-2017

% of ROCE Tranche vesting

11% or less

Nil

Above 11% but less than 14%

Between 0% and 100% on astraight-line basis

14% and above

100%

 

2. The remaining one third of the award is subject to a condition as to the cumulative underlying earnings per share (EPS) over the Performance Period (the "EPS Tranche"). The period over which the EPS performance condition will be measured will be the period of three financial years 31 December 2015, 2016 and 2017.

Cumulative Underlying EPS forFY2015-2017

% of EPS Tranche vesting

Less than 38 pence

Nil

38 pence to 48 pence

25% to 100% on astraight-line basis

Above 48 pence

100%

 

 

R C Monro

Company Secretary 0114 285 6355

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSFESAAFISELU
Date   Source Headline
8th Jun 20264:44 pmRNSDirector/PDMR Shareholding
3rd Jun 20263:50 pmRNSDirector/PDMR Shareholding
28th May 20262:56 pmRNSDirector/PDMR Shareholding
22nd May 20261:36 pmRNSDirector/PDMR Shareholding
22nd May 20261:29 pmRNSDirector/PDMR Shareholding
22nd May 20261:18 pmRNSResult of Meeting
20th May 20263:07 pmRNSDirector/PDMR Shareholding
14th May 20264:44 pmRNSDirector/PDMR Shareholding
13th May 20265:27 pmRNSDirector/PDMR Shareholding
6th May 202611:11 amRNSDirector/PDMR Shareholding
6th May 202610:24 amRNSNotice of GM
30th Apr 20262:00 pmRNSResult of AGM
30th Apr 20267:01 amRNSTrading Update
30th Apr 20267:00 amRNSAppointment of Chief Financial Officer
10th Apr 20267:00 amRNSDirectorate change
23rd Mar 202610:57 amRNSDirector/PDMR Shareholding
23rd Mar 20269:59 amRNSNotice of AGM
4th Mar 202610:18 amRNSAnnual Financial Report
4th Mar 20267:00 amRNSFull year results for year ended 31 December 2025
15th Jan 20264:02 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNS2025 Full Year Trading Update & Strategy Framework
19th Dec 20257:00 amRNSNotice of Trading & Business Update
19th Dec 20257:00 amRNSNotice of Trading & Business Update
23rd Oct 202511:05 amRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSQ3 Trading Update
1st Oct 20259:00 amRNSDirector/PDMR Shareholding
3rd Sep 202510:54 amRNSHolding(s) in Company
28th Aug 20251:02 pmRNSResult of Meeting
8th Aug 202511:01 amRNSNotice of GM
5th Aug 20257:00 amRNSResults for the six months to 30 June 2025
8th Jul 20257:01 amRNSAppointment of CEO and Chair designate
8th Jul 20257:00 amRNSH1 Trading Update
9th May 20257:00 amRNSDirectorate Change
6th May 20253:00 pmRNSHolding(s) in Company
1st May 20253:12 pmRNSResult of AGM
30th Apr 20257:00 amRNSTrading Update
10th Apr 20254:02 pmRNSDirector/PDMR Shareholding
4th Apr 202511:10 amRNSDirector/PDMR Shareholding
1st Apr 20254:00 pmRNSHolding(s) in Company
28th Mar 20255:03 pmRNSDirector/PDMR Shareholding
28th Mar 20254:59 pmRNSDirector/PDMR Shareholding
24th Mar 202510:06 amRNSNotice of AGM
21st Mar 20254:44 pmRNSDirector/PDMR Shareholding
12th Mar 20259:06 amRNSDirector/PDMR Shareholding
12th Mar 20258:54 amRNSDirectorate Change
10th Mar 20258:32 amRNSDirector/PDMR Shareholding
5th Mar 202511:17 amRNSAnnual Financial Report
5th Mar 20257:00 amRNSFull year results for year ended 31 December 2024
4th Mar 202512:52 pmRNSHolding(s) in Company
19th Feb 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.